230 related articles for article (PubMed ID: 3123278)
1. Comparison of pulsatile subcutaneous gonadotropin-releasing hormone and exogenous gonadotropins in the treatment of men with isolated hypogonadotropic hypogonadism.
Liu L; Chaudhari N; Corle D; Sherins RJ
Fertil Steril; 1988 Feb; 49(2):302-8. PubMed ID: 3123278
[TBL] [Abstract][Full Text] [Related]
2. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
3. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
Büchter D; Behre HM; Kliesch S; Nieschlag E
Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
[TBL] [Abstract][Full Text] [Related]
4. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
Ley SB; Leonard JM
J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
[TBL] [Abstract][Full Text] [Related]
5. Pulsatile gonadotropin releasing hormone therapy for spermatogenesis in congenital hypogonadotropic hypogonadism patients who had poor response to combined gonadotropin therapy.
Huang Z; Wang X; Yu B; Ma W; Zhang P; Wu X; Nie M; Mao J
Arch Endocrinol Metab; 2024 May; 68():e230101. PubMed ID: 38739523
[TBL] [Abstract][Full Text] [Related]
6. Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism.
Lin J; Mao J; Wang X; Ma W; Hao M; Wu X
Medicine (Baltimore); 2019 Aug; 98(31):e16616. PubMed ID: 31374027
[TBL] [Abstract][Full Text] [Related]
7. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.
Depenbusch M; von Eckardstein S; Simoni M; Nieschlag E
Eur J Endocrinol; 2002 Nov; 147(5):617-24. PubMed ID: 12444893
[TBL] [Abstract][Full Text] [Related]
9. [Spermatogenesis of pulsatile gonadotropin-releasing hormone infusion versus gonadotropin therapy in male idiopathic hypogonadotropic hypogonadism].
Huang B; Mao J; Xu H; Wang X; Liu Z; Nie M; Wu X
Zhonghua Yi Xue Za Zhi; 2015 May; 95(20):1568-71. PubMed ID: 26463603
[TBL] [Abstract][Full Text] [Related]
10. Pulsatile gonadotropin-releasing hormone treatment of men with idiopathic hypogonadotropic hypogonadism.
Christiansen P; Skakkebaek NE
Horm Res; 2002; 57(1-2):32-6. PubMed ID: 12006717
[TBL] [Abstract][Full Text] [Related]
11. Pulsatile Gonadotropin-Releasing Hormone Therapy Is Associated With Better Spermatogenic Outcomes than Gonadotropin Therapy in Patients With Pituitary Stalk Interruption Syndrome.
Zhang J; Zhu Y; Zhang R; Liu H; Sun B; Zhang W; Wang X; Nie M; Mao J; Wu X
Endocr Pract; 2024 Feb; 30(2):146-154. PubMed ID: 38029930
[TBL] [Abstract][Full Text] [Related]
12. Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism.
Kirk JM; Savage MO; Grant DB; Bouloux PM; Besser GM
Clin Endocrinol (Oxf); 1994 Jul; 41(1):57-63. PubMed ID: 7914153
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism.
Liu Y; Ren XY; Peng YG; Chen SK; Cheng XR; Qin M; Wang XL; Song YN; Fan LJ; Gong CX
Chin Med J (Engl); 2021 Mar; 134(10):1152-1159. PubMed ID: 33813517
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism.
Finkel DM; Phillips JL; Snyder PJ
N Engl J Med; 1985 Sep; 313(11):651-5. PubMed ID: 3927163
[TBL] [Abstract][Full Text] [Related]
15. Induction of spermatogenesis and fertility in hypogonadotropic azoospermic men by intravenous pulsatile gonadotropin-releasing hormone (GnRH).
Blumenfeld Z; Makler A; Frisch L; Brandes JM
Gynecol Endocrinol; 1988 Jun; 2(2):151-64. PubMed ID: 3055820
[TBL] [Abstract][Full Text] [Related]
16. Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin-releasing hormone in patients with hypogonadotrophic hypogonadism.
Delemarre-Van de Waal HA
Clin Endocrinol (Oxf); 1993 May; 38(5):473-80. PubMed ID: 8330443
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size.
Burris AS; Rodbard HW; Winters SJ; Sherins RJ
J Clin Endocrinol Metab; 1988 Jun; 66(6):1144-51. PubMed ID: 3372679
[TBL] [Abstract][Full Text] [Related]
18. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects.
Delemarre-van de Waal HA
Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U89-94. PubMed ID: 15554892
[TBL] [Abstract][Full Text] [Related]
19. Successful GnRH treatment in a patient with Kallmann's syndrome, who previously failed HMG/HCG treatment.
Berezin M; Weissenberg R; Rabinovitch O; Lunenfeld B
Andrologia; 1988; 20(4):285-8. PubMed ID: 3143274
[TBL] [Abstract][Full Text] [Related]
20. Induction of puberty in a patient with hypogonadotropic hypogonadism: effect of sequentially applied hCG and pulsatile GnRH administration.
Klingmüller D; Menger D; Wildt L; Leyendecker G; Krück F; Schweikert HU
Horm Metab Res; 1985 Jul; 17(7):358-61. PubMed ID: 3928472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
